INTRODUCTION: The aim was to monitor the changes in haemocoagulation parameters in healthy volunteers after a thrombotripsy with 1-hour transcranial Doppler monitoring using a 2-4 MHz probe. MATERIALS AND METHODS: About 10 healthy volunteers underwent a 1-hour thrombotripsy of the middle cerebral artery (MCA), thrombotripsy of the radial artery and a standard 20-min neurosonologic examination (NSE) in 2-week intervals. Platelet count, aPTT, prothrombin time, fibrinogen, D-dimers, tPA, FDP, alpha-2-antiplasmin (AP), plasminogen, PAI-1 antigen, time of euglobulin clot lysis (ECL), homocysteine, and lipoprotein (a) were examined before, at the end and 24 h after a thrombotripsy. All adverse events were monitored. RESULTS: After a thrombotripsy of the MCA, PAI-1 antigen, tPA antigen, fibrinogen and AP activity were significantly decreased by a mean of 32, 23, 7, and 4% respectively (P < 0.05 in all cases). After a thrombotripsy of the RA, there was a significant decrease in tPA antigen alone by an average of 14% (P < 0.05). Standard NSE did not affect any of the measured factors. CONCLUSIONS: Thrombotripsy with 1-hour TCD monitoring using a 2-4 MHz diagnostic probe may affect the fibrinolytic system in humans.
INTRODUCTION: The aim was to monitor the changes in haemocoagulation parameters in healthy volunteers after a thrombotripsy with 1-hour transcranial Doppler monitoring using a 2-4 MHz probe. MATERIALS AND METHODS: About 10 healthy volunteers underwent a 1-hour thrombotripsy of the middle cerebral artery (MCA), thrombotripsy of the radial artery and a standard 20-min neurosonologic examination (NSE) in 2-week intervals. Platelet count, aPTT, prothrombin time, fibrinogen, D-dimers, tPA, FDP, alpha-2-antiplasmin (AP), plasminogen, PAI-1 antigen, time of euglobulin clot lysis (ECL), homocysteine, and lipoprotein (a) were examined before, at the end and 24 h after a thrombotripsy. All adverse events were monitored. RESULTS: After a thrombotripsy of the MCA, PAI-1 antigen, tPA antigen, fibrinogen and AP activity were significantly decreased by a mean of 32, 23, 7, and 4% respectively (P < 0.05 in all cases). After a thrombotripsy of the RA, there was a significant decrease in tPA antigen alone by an average of 14% (P < 0.05). Standard NSE did not affect any of the measured factors. CONCLUSIONS: Thrombotripsy with 1-hour TCD monitoring using a 2-4 MHz diagnostic probe may affect the fibrinolytic system in humans.
Authors: C W Francis; P T Onundarson; E L Carstensen; A Blinc; R S Meltzer; K Schwarz; V J Marder Journal: J Clin Invest Date: 1992-11 Impact factor: 14.808
Authors: Matthias Reinhard; Andreas Hetzel; Sebastian Krüger; Stefan Kretzer; Jochen Talazko; Sargon Ziyeh; Johannes Weber; Thomas Els Journal: Stroke Date: 2006-04-27 Impact factor: 7.914
Authors: Michael Daffertshofer; Achim Gass; Peter Ringleb; Matthias Sitzer; Ulrich Sliwka; Thomas Els; Oliver Sedlaczek; Walter J Koroshetz; Michael G Hennerici Journal: Stroke Date: 2005-06-09 Impact factor: 7.914
Authors: Andrei V Alexandrov; Andrew M Demchuk; W Scott Burgin; David J Robinson; James C Grotta Journal: J Neuroimaging Date: 2004-04 Impact factor: 2.486
Authors: Kelly L Dunn; Jonathan P Wolf; David M Dorfman; Patricia Fitzpatrick; James L Baker; Samuel Z Goldhaber Journal: J Am Coll Cardiol Date: 2002-10-16 Impact factor: 24.094
Authors: David Skoloudík; Michal Bar; Daniel Sanák; Petr Bardon; Martin Roubec; Katerina Langová; Roman Herzig; Petr Kanovský Journal: J Thromb Thrombolysis Date: 2010-05 Impact factor: 2.300
Authors: M Kuliha; M Roubec; T Jonszta; J Krajca; D Czerny; A Krajina; K Langová; R Herzig; V Procházka; D Školoudík Journal: AJNR Am J Neuroradiol Date: 2013-01-31 Impact factor: 3.825
Authors: Tomáš Hrbáč; David Netuka; Vladimír Beneš; Vladimír Nosáľ; Petra Kešnerová; Aleš Tomek; Táňa Fadrná; Vladimír Beneš; Jiří Fiedler; Vladimír Přibáň; Miroslav Brozman; Kateřina Langová; Roman Herzig; David Školoudík Journal: Trials Date: 2017-01-17 Impact factor: 2.279